First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.
- DOI
- 10.1158/1535-7163.mct-23-0065
- Published
- 2023 Oct 2
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-23-0065,
title = {First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.},
author = {Hamilton EP and Wang JS and Oza AM and Patel MR and Ulahannan SV and Bauer T and Karlix JL and Zeron-Medina J and Fabbri G and Marco-Casanova P and Moorthy G and Hattersley MM and Littlewood GM and Mitchell P and Saeh J and Pouliot GP and Moore KN},
year = {2023},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-23-0065},
url = {https://doi.org/10.1158/1535-7163.mct-23-0065}
}RIS
TY - JOUR TI - First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. AU - Hamilton EP AU - Wang JS AU - Oza AM AU - Patel MR AU - Ulahannan SV AU - Bauer T AU - Karlix JL AU - Zeron-Medina J AU - Fabbri G AU - Marco-Casanova P AU - Moorthy G AU - Hattersley MM AU - Littlewood GM AU - Mitchell P AU - Saeh J AU - Pouliot GP AU - Moore KN PY - 2023 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-23-0065 UR - https://doi.org/10.1158/1535-7163.mct-23-0065 ER -
APA
EP, H., JS, W., AM, O., MR, P., SV, U., T, B., JL, K., J, Z., G, F., P, M., G, M., MM, H., GM, L., P, M., J, S., GP, P., & KN, M. (2023). First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-23-0065
Source records
- pubmed · retrieved 2026-09-26T16:01:35.548Z